| BTASuspension from Official Quotation |
| 30/10/12 | PRICE SENSITIVE | 101.45KB | Share |
|
| BTASupreme Court of Victoria approves scheme of arrangement |
| 26/10/12 | PRICE SENSITIVE | 103.25KB | Share |
|
| BTAResults of Biota shareholder meeting |
| 23/10/12 | PRICE SENSITIVE | 184.3KB | Share |
|
| BTANabi shareholder meeting results |
| 23/10/12 | PRICE SENSITIVE | 102.13KB | Share |
|
| BTAMerger update, determination of VWAP & share ratios |
| 19/10/12 | PRICE SENSITIVE | 65.17KB | Share |
|
| BTABiota and Nabi announce Revised Merger Terms |
| 18/09/12 | PRICE SENSITIVE | 864.17KB | Share |
|
| BTAUpdate in respect of CEO for Biota Pharmaceuticals |
| 07/09/12 | PRICE SENSITIVE | 91.25KB | Share |
|
| BTAOpen Briefing - CEO on F12 results |
| 22/08/12 | PRICE SENSITIVE | 153.44KB | Share |
|
| BTAPreliminary Final Report |
| 22/08/12 | PRICE SENSITIVE | 513.43KB | Share |
|
| BTAInavir prevention study achieves primary endpoint |
| 22/08/12 | PRICE SENSITIVE | 93.67KB | Share |
|
| BTAOpen Briefing - CEO on Nabi Merger |
| 20/08/12 | PRICE SENSITIVE | 186.55KB | Share |
|
| BTAInavir June Quarter (Q4) Royalty |
| 31/07/12 | PRICE SENSITIVE | 80.37KB | Share |
|
| BTARoyalties from Relenza for Q4 and F2012 |
| 26/07/12 | PRICE SENSITIVE | 80.18KB | Share |
|
| BTAShareholder Update |
| 23/07/12 | PRICE SENSITIVE | 54.79KB | Share |
|
| BTAShareholder Update |
| 21/05/12 | PRICE SENSITIVE | 80.85KB | Share |
|
| BTAFinancial update |
| 16/05/12 | PRICE SENSITIVE | 191.89KB | Share |
|
| BTAInavir March Quarter (Q3) Royalty |
| 11/05/12 | PRICE SENSITIVE | 80.2KB | Share |
|
| BTARelenza March Quarter Royalty |
| 26/04/12 | PRICE SENSITIVE | 73.77KB | Share |
|
| BTABiota and Nabi Announce Proposed Merger |
| 23/04/12 | PRICE SENSITIVE | 907.07KB | Share |
|
| BTAHRV Phase IIb Study Achieves Primary Endpoint |
| 28/03/12 | PRICE SENSITIVE | 125.51KB | Share |
|
| BTAResponse to an ASX price query |
| 21/03/12 | PRICE SENSITIVE | 214.16KB | Share |
|
| BTAOpen Briefing - CEO on 1H Results and Outlook |
| 15/02/12 | PRICE SENSITIVE | 222.75KB | Share |
|
| BTAHalf Yearly Report and Accounts |
| 15/02/12 | PRICE SENSITIVE | 803.02KB | Share |
|
| BTAInavir Phase III prevention study detail |
| 13/02/12 | PRICE SENSITIVE | 74.77KB | Share |
|
| BTARelenza December Quarterly Royalty |
| 08/02/12 | PRICE SENSITIVE | 74.25KB | Share |
|
| BTAInavir Q2 royalties |
| 31/01/12 | PRICE SENSITIVE | 73.67KB | Share |
|
| BTAInavir sales update |
| 31/10/11 | PRICE SENSITIVE | 72.7KB | Share |
|
| BTARelenza September Quarter Royalty |
| 27/10/11 | PRICE SENSITIVE | 73.68KB | Share |
|
| BTAPreliminary Final Report |
| 17/08/11 | PRICE SENSITIVE | 187.07KB | Share |
|
| BTARoyalties from Inavir for Q4 and F2011 |
| 29/07/11 | PRICE SENSITIVE | 37.49KB | Share |
|
| BTARoyalties from Relenza for Q4 and F2011 |
| 27/07/11 | PRICE SENSITIVE | 37.72KB | Share |
|
| BTAPhase III prophylaxis trial for CS-8958 |
| 27/06/11 | PRICE SENSITIVE | 55.38KB | Share |
|
| BTABiota obtains US$2.9m NIH grant for novel antibacterial |
| 10/06/11 | PRICE SENSITIVE | 45.78KB | Share |
|
| BTAInavir Royalty for March 2011 quarter |
| 12/05/11 | PRICE SENSITIVE | 37.69KB | Share |
|
| BTARelenza Royalty for March 2011 quarter |
| 28/04/11 | PRICE SENSITIVE | 35.12KB | Share |
|
| BTABARDA awards major contract to Biota |
| 01/04/11 | PRICE SENSITIVE | 92.18KB | Share |
|
| BTAOpen Briefing - CEO on Outlook, LANI Potential |
| 16/02/11 | PRICE SENSITIVE | 189.25KB | Share |
|
| BTAHalf Year Report and Accounts |
| 16/02/11 | PRICE SENSITIVE | 1.29MB | Share |
|
| BTARelenza Royalty for December 2010 quarter |
| 04/02/11 | PRICE SENSITIVE | 35.18KB | Share |
|
| BTAInavir Royalty for December 2010 quarter |
| 01/02/11 | PRICE SENSITIVE | 37.39KB | Share |
|
| BTAResponse to ASX Price Query |
| 10/01/11 | PRICE SENSITIVE | 115.43KB | Share |
|
| BTARelenza September Quarter Royalty |
| 22/10/10 | PRICE SENSITIVE | 35.08KB | Share |
|
| BTAInavir launch in Japan |
| 19/10/10 | PRICE SENSITIVE | 42.19KB | Share |
|
| BTAInavir approved for sale in Japan |
| 13/09/10 | PRICE SENSITIVE | 217.04KB | Share |
|
| BTAPreliminary Final Report |
| 18/08/10 | PRICE SENSITIVE | 447.86KB | Share |
|
| BTAHRV Phase II trial underway in patients |
| 26/07/10 | PRICE SENSITIVE | 92.49KB | Share |
|
| BTARoyalties from Relenza for Q4 and F2010 |
| 22/07/10 | PRICE SENSITIVE | 116.43KB | Share |
|
| BTARelenza royalty for March 2010 quarter |
| 29/04/10 | PRICE SENSITIVE | 162.64KB | Share |
|
| BTAHCV research agreement concludes |
| 20/04/10 | PRICE SENSITIVE | 156.27KB | Share |
|
| BTABiota announces half year net profit of $33.5m |
| 17/02/10 | PRICE SENSITIVE | 290.03KB | Share |
|
| BTARelenza royalty for December 2009 quarter |
| 05/02/10 | PRICE SENSITIVE | 156.72KB | Share |
|
| BTAResponse to ASX Query |
| 15/12/09 | PRICE SENSITIVE | 169.69KB | Share |
|
| BTA2009 AGM Addresses |
| 12/11/09 | PRICE SENSITIVE | 790.77KB | Share |
|
| BTABiota acquires the antibacterial assets of MaxThera Inc |
| 12/11/09 | PRICE SENSITIVE | 203.74KB | Share |
|
| BTABiota acquires the antibacterial assets of Prolysis Ltd |
| 12/11/09 | PRICE SENSITIVE | 204.77KB | Share |
|
| BTACS-8958 Phase III prevention study underway |
| 05/11/09 | PRICE SENSITIVE | 101.4KB | Share |
|
| BTARelenza Q1 Royalty |
| 29/10/09 | PRICE SENSITIVE | 155.04KB | Share |
|
| BTAOpen Briefing-CEO on F09 Results and Capital Return |
| 19/08/09 | PRICE SENSITIVE | 67.24KB | Share |
|
| BTA2009 Preliminary Final Report and Annual Report |
| 19/08/09 | PRICE SENSITIVE | 800.88KB | Share |
|
| BTABiota to return $20 million to shareholders |
| 13/08/09 | PRICE SENSITIVE | 159.07KB | Share |
|
| BTALANI Phase III clinical trials in Asia prove successful |
| 10/08/09 | PRICE SENSITIVE | 136KB | Share |
|
| BTARSV program returned to Biota |
| 10/08/09 | PRICE SENSITIVE | 88.32KB | Share |
|
| BTAGSK Relenza capacity to triple |
| 23/07/09 | PRICE SENSITIVE | 130KB | Share |
|
| BTARelenza Q4 royalties $8.9 million |
| 23/07/09 | PRICE SENSITIVE | 155.31KB | Share |
|
| BTAHRV phase IIa study achieves clinical proof-of-concept |
| 11/06/09 | PRICE SENSITIVE | 106.79KB | Share |
|
| BTAAustralia adds 1.6m Relenza courses to National Stockpile |
| 29/05/09 | PRICE SENSITIVE | 79.14KB | Share |
|
| BTAImportant GSK initiatives to new influenza A (H1N1) strain |
| 04/05/09 | PRICE SENSITIVE | 188.74KB | Share |
|
| BTARelenza Q3 royalty $32.3m |
| 23/04/09 | PRICE SENSITIVE | 88.53KB | Share |
|
| BTAResponse to an ASX Query |
| 22/04/09 | PRICE SENSITIVE | 167.4KB | Share |
|
| BTADaiichi Sankyo exercise right to CS-8958 in Japan |
| 30/03/09 | PRICE SENSITIVE | 92.93KB | Share |
|
| BTAOpen Briefing - CEO on H1 Result and Outlook |
| 18/02/09 | PRICE SENSITIVE | 60.15KB | Share |
|
| BTABiota announces half year profit |
| 18/02/09 | PRICE SENSITIVE | 715.28KB | Share |
|
| BTARevised Relenza Royalty Dec 2008 |
| 13/02/09 | PRICE SENSITIVE | 90KB | Share |
|
| BTAGSK imports additional Relenza to Japan |
| 11/02/09 | PRICE SENSITIVE | 156.76KB | Share |
|
| BTARelenza royalty for December 2008 quarter |
| 06/02/09 | PRICE SENSITIVE | 88KB | Share |
|
| BTAUK orders 10.6m Relenza courses |
| 30/01/09 | PRICE SENSITIVE | 396.48KB | Share |
|
